Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/618,862, filed Apr 2, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,095,552 | Modified Polynucleotides Encoding Copper Metabolism (MURR1) Domain Containing 1 In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 9,107,886 | Modified Polynucleotides Encoding Basic Helix-Loop-Helix Family, Member E41 In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 9,114,113 | Modified Polynucleotides Encoding CITED4 In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 9,220,792 | Modified Polynucleotides Encoding AQUAPORIN-5 In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 9,233,141 | Modified Polynucleotides for the Production of Proteins Associated with Blood and Lymphatic Disorders In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 10,772,975 | Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 8,999,380 | Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease In force · High confidence | ModernaTX, Inc. | In force | High confidence | ||
| US 9,814,760 | Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease Lapsed Nov 14, 2025 on the fee record High confidence | ModernaTX, Inc. | Lapsed Nov 14, 2025 on the fee record | High confidence | ||
| Application 17/020,522 | Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease Abandoned Abandoned Apr 10, 2025 | ModernaTX, Inc. | Abandoned | Abandoned Apr 10, 2025 | ||
| Application 18/760,652 | Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease Pending Not granted | Moderna TX, Inc. | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by ModernaTX, Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.